Benitec Biopharma (BNTC) Total Liabilities (2019 - 2025)

Benitec Biopharma has reported Total Liabilities for 7 years, with the latest figure at $3.3 million in Q4 2025.

• Quarterly Total Liabilities changed N/A year-over-year to $3.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 million (changed N/A YoY) and the FY2025 annual result came in at $2.3 million, down 53.71% from the prior year.
• Total Liabilities rose to $3.3 million in Q4 2025 per BNTC's latest filing, from $2.4 million in the prior quarter.
• Over five years, Total Liabilities peaked at $7.6 million in Q1 2025 and troughed at $1.4 million in Q2 2021.
• A 5-year average of $3.6 million and a median of $3.3 million in 2025 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2021 and 2025: Total Liabilities jumped 258.29% in 2021, then slumped 53.71% in 2025.
• Over 5 years, Total Liabilities stood at $3.2 million in 2021, then fell by 8.4% to $2.9 million in 2022, then soared by 102.1% to $5.9 million in 2023, then slipped by 21.91% to $4.6 million in 2024, then fell by 27.73% to $3.3 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $3.3 million, $2.4 million, and $2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.